Hana Golding - Publications, H-index & Citations

Hana Golding

food and drug administration

60H指数

251论文数

1.3W被引数

收录论文 99

发表时间

Development of in vitro airway epithelial model to assess immune response and safety of mucosal adjuvants 体外气道上皮模型的开发，以评估黏膜佐剂的免疫反应和安全性

npj Vaccines

IF6.5

2026-04-22

OAAI

David Acosta; Mohammad Rubel Hoq; Kazuyo Takeda; Chad D. Costley; Hana Golding; Marina Zaitseva

Acute and persistent responses after H5N1 vaccination in humans 人类接种H5N1疫苗后的急性和持续性反应

CELL REPORTS

IF6.9

2024-09-01

OAAI

Apps, Richard; Biancotto, Angelique; Candia, Julian; Kotliarov, Yuri; Perl, Shira; Cheung, Foo; Farmer, Rohit; Mule, Matthew P.; Rachmaninoff, Nicholas; Chen, Jinguo; Martins, Andrew J.; Shi, Rongye; Zhou, Huizhi; Bansal, Neha; Schum, Paula; Olnes, Matthew J.; Milanez-Almeida, Pedro; Han, Kyu Lee; Sellers, Brian; Cortese, Mario; Hagan, Thomas; Rouphael, Nadine; Pulendran, Bali; King, Lisa; Manischewitz, Jody; Khurana, Surender; Golding, Hana; van der Most, Robbert G.; Dickler, Howard B.; Germain, Ronald N.; Schwartzberg, Pamela L.; Tsang, John S.

Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus

NATURE MEDICINE

IF50

2024-07-16

PREAI

Khurana, Surender; King, Lisa R.; Manischewitz, Jody; Posadas, Olivia; Mishra, Ashish K.; Liu, Dongxiao; Beigel, John H.; Rappuoli, Rino; Tsang, John S.; Golding, Hana

Monoclonal antibodies targeting sites in respiratory syncytial virus attachment G protein provide protection against RSV-A and RSV-B in mice

NATURE COMMUNICATIONS

IF15.7

2024-04-04

OAAI

Lee, Youri; Klenow, Laura; Coyle, Elizabeth M.; Grubbs, Gabrielle; Golding, Hana; Khurana, Surender

Pyrogenic and inflammatory mediators are produced by polarized M1 and M2 macrophages activated with D-dimer and SARS-CoV-2 spike immune complexes

CYTOKINE

IF3.7

2024-01-01

OAAI

Park, Yun-Jong; Acosta, David; Hoq, Mohammad Rubel; Khurana, Surender; Golding, Hana; Zaitseva, Marina

Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2023-04-17

OAAI

Bellusci, Lorenza; Golding, Hana; Khurana, Surender

Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine

NATURE COMMUNICATIONS

IF15.7

2022-10-23

OAAI

Li, Dapeng; Martinez, David R.; Schafer, Alexandra; Chen, Haiyan; Barr, Maggie; Sutherland, Laura L.; Lee, Esther; Parks, Robert; Mielke, Dieter; Edwards, Whitney; Newman, Amanda; Bock, Kevin W.; Minai, Mahnaz; Nagata, Bianca M.; Gagne, Matthew; Douek, Daniel; DeMarco, C. Todd; Denny, Thomas N.; Oguin, Thomas H., III; Brown, Alecia; Rountree, Wes; Wang, Yunfei; Mansouri, Katayoun; Edwards, Robert J.; Ferrari, Guido; Sempowski, Gregory D.; Eaton, Amanda; Tang, Juanjie; Cain, Derek W.; Santra, Sampa; Pardi, Norbert; Weissman, Drew; Tomai, Mark; Fox, Christopher; Moore, Ian N.; Andersen, Hanne; Lewis, Mark G.; Golding, Hana; Khurana, Surender; Seder, Robert; Baric, Ralph S.; Montefiori, David C.; Saunders, Kevin O.; Haynes, Barton F.

Untitled Reply

CLINICAL INFECTIOUS DISEASES

IF7.3

2022-09-08

OAAI

Golding, Hana; Khurana, Surender

Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Intravenous Human Immunoglobulins Neutralizes Omicron Subvariants BA.1, BA.2, BA.2.12.1, BA.3, and BA.4/BA.5 for Treatment of Coronavirus Disease 2019 新型冠状病毒超免疫静脉内人免疫球蛋白中和Omicron亚变体BA.1，BA.2，BA.2.12.1，BA.3和BA.4/BA.5治疗冠状病毒病2019

CLINICAL INFECTIOUS DISEASES

IF7.3

2022-09-01

OAAI

Awasthi, Mayanka; Golding, Hana; Khurana, Surender

Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination

NATURE COMMUNICATIONS

IF15.7

2022-08-08

OAAI

Bellusci, Lorenza; Grubbs, Gabrielle; Zahra, Fatema Tuz; Forgacs, David; Golding, Hana; Ross, Ted M.; Khurana, Surender

D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes

PLOS PATHOGENS

IF4.9

2022-04-06

OAAI

Park, Yun-Jong; Acosta, David; Vassell, Russell; Tang, Juanjie; Khurana, Surender; Weiss, Carol D.; Golding, Hana; Zaitseva, Marina

Immune Response to SARS-CoV-2 Vaccine and Following Breakthrough Omicron Infection in an Autoimmune Patient with Hashimoto's Thyroiditis, Pernicious Anemia, and Chronic Atrophic Autoimmune Gastritis: A Case Report

VACCINES

IF3.4

2022-03-15

OAAI

Cluff, Emily; Bellusci, Lorenza; Golding, Hana; Khurana, Surender

A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2022-01-26

OAAI

Martinez, David R.; Schafer, Alexandra; Gobeil, Sophie; Li, Dapeng; De la Cruz, Gabriela; Parks, Robert; Lu, Xiaozhi; Barr, Maggie; Stalls, Victoria; Janowska, Katarzyna; Beaudoin, Esther; Manne, Kartik; Mansouri, Katayoun; Edwards, Robert J.; Cronin, Kenneth; Yount, Boyd; Anasti, Kara; Montgomery, Stephanie A.; Tang, Juanjie; Golding, Hana; Shen, Shaunna; Zhou, Tongqing; Kwong, Peter D.; Graham, Barney S.; Mascola, John R.; Montefiori, David C.; Alam, S. Munir; Sempowski, Gregory; Sempowski, Gregory D.; Khurana, Surender; Wiehe, Kevin; Saunders, Kevin O.; Acharya, Priyamvada; Haynes, Barton F.; Baric, Ralph S.

Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex

EBIOMEDICINE

IF10.8

2021-12-01

OAAI

Tang, Juanjie; Grubbs, Gabrielle; Lee, Youri; Huang, Chang; Ravichandran, Supriya; Forgacs, David; Golding, Hana; Ross, Ted M.; Khurana, Surender

Protective antigenic sites identified in respiratory syncytial virus fusion protein reveals importance of p27 domain

EMBO MOLECULAR MEDICINE

IF8.3

2021-11-08

OAAI

Lee, Jeehyun; Lee, Youri; Klenow, Laura; Coyle, Elizabeth M.; Tang, Juanjie; Ravichandran, Supriya; Golding, Hana; Khurana, Surender

Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2-infected individuals reveal unlinked immune signatures

SCIENCE ADVANCES

IF12.5

2021-10-15

OAAI

Ravichandran, Supriya; Grubbs, Gabrielle; Tang, Juanjie; Lee, Youri; Huang, Chang; Golding, Hana; Khurana, Surender

Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Adult Syrian Hamsters

CLINICAL INFECTIOUS DISEASES

IF7.3

2021-09-23

OAAI

Stauft, Charles B.; Tegenge, Million; Khurana, Surender; Lee, Youri; Selvaraj, Prabhuanand; Golding, Hana; Wang, Tony; Golding, Basil

Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial

NPJ VACCINES

IF6.5

2021-07-14

OAAI

Rouphael, Nadine G.; Lai, Lilin; Tandon, Sonia; McCullough, Michele Paine; Kong, Yunchuan; Kabbani, Sarah; Natrajan, Muktha S.; Xu, Yongxian; Zhu, Yerun; Wang, Dongli; O'Shea, Jesse; Sherman, Amy; Yu, Tianwei; Henry, Sebastien; McAllister, Devin; Stadlbauer, Daniel; Khurana, Surender; Golding, Hana; Krammer, Florian; Mulligan, Mark J.; Prausnitz, Mark R.

Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients 恢复期血浆治疗对冠状病毒病2019 (新型冠状病毒肺炎) 患者新型冠状病毒 (SARS-CoV-2) 抗体谱的影响

CLINICAL INFECTIOUS DISEASES

IF7.3

2021-04-16

OAAI

Tang, Juanjie; Grubbs, Gabrielle; Lee, Youri; Golding, Hana; Khurana, Surender

Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients

NATURE COMMUNICATIONS

IF15.7

2021-02-22

OAAI

Tang, Juanjie; Ravichandran, Supriya; Lee, Youri; Grubbs, Gabrielle; Coyle, Elizabeth M.; Klenow, Laura; Genser, Hollie; Golding, Hana; Khurana, Surender

研究方向